What lab tests should be ordered to diagnose C1 (complement component 1) esterase inhibitor deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Testing for C1 Esterase Inhibitor Deficiency

Begin with a complement C4 level as the initial screening test, followed by both C1 inhibitor antigenic level and C1 inhibitor functional level if C4 is low. 1, 2

Initial Screening Test

  • Order complement C4 level first as the most cost-effective screening strategy for C1 inhibitor deficiency 1
  • At least 95% of patients with C1 inhibitor deficiency will have a reduced C4 level even between attacks, increasing to virtually 100% during angioedema attacks 1, 3
  • A normal C4 level during an attack of angioedema strongly suggests an alternative diagnosis rather than C1 inhibitor deficiency 1, 3
  • Critical caveat: Send C4 to the laboratory promptly, as degradation can cause artificially low results if there is significant delay in transfer 1

Confirmatory Testing When C4 is Low

If C4 is low, proceed with:

  • C1 inhibitor antigenic (protein) level 1, 2
  • C1 inhibitor functional activity level 1, 2
  • Both tests are required to distinguish between Type I HAE, Type II HAE, and acquired C1 inhibitor deficiency 1, 2

Interpretation of Results:

  • Type I HAE (85% of cases): Low C4 + low C1 inhibitor antigen + low C1 inhibitor function 1, 2, 3
  • Type II HAE (15% of cases): Low C4 + normal (or elevated) C1 inhibitor antigen + low C1 inhibitor function 1, 2, 3
  • Acquired C1 inhibitor deficiency: Low C4 + low C1 inhibitor antigen/function + low C1q 2, 4

Additional Testing for Acquired Forms

  • Order C1q level when acquired C1 inhibitor deficiency is suspected (typically in older adults with no family history) 2, 4
  • Low C1q distinguishes acquired from hereditary forms 2, 4
  • Consider screening for underlying lymphoproliferative disorders or autoimmune conditions in acquired cases 1, 4

Technical Considerations

  • Use chromogenic functional assays for C1 inhibitor function rather than ELISA-based assays, as they provide superior accuracy 2, 5
  • Functional C1 inhibitor level should be less than 50-60% of the lower limit of normal to be compatible with hereditary angioedema 2
  • Repeat positive screening results once to exclude ex vivo sample degradation or laboratory error 2
  • Hemolytic complement assays are most accurate but technically difficult and not readily available 2

Special Clinical Situations

  • During pregnancy: C1 inhibitor levels decrease due to increased plasma volume, so interpret results cautiously 2
  • In children: C1 inhibitor and C4 levels reach mature adult levels between 6-36 months and 2-3 years of age, respectively 2
  • If patient is on treatment: C4 levels can normalize; repeat testing during an angioedema attack for accurate assessment 2

When All Tests Are Normal

  • If C4, C1 inhibitor antigen, and C1 inhibitor function are all normal, C1 inhibitor deficiency is excluded 1
  • Consider hereditary angioedema with normal C1 inhibitor levels (HAE-nl-C1-INH) if there is strong family history and recurrent angioedema 1, 3
  • Genetic testing for mutations in factor XII, angiopoietin-1, plasminogen, kininogen, myoferlin, and HS3ST6 may be pursued for HAE-nl-C1-INH 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis of C1 Esterase Inhibitor Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to Angioedema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acquired C1 esterase inhibitor deficiency.

Annals of internal medicine, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.